Dr. Gallia Levy saw the early clinical data around a potential hemophilia A drug that Roche affiliate Chugai Pharmaceutical had developed. Now it was coming to Genentech, and Levy wanted to be there, too.
Ron Leuty, Biz Journals
Tue, 11/21/2017 - 8:04am
Dr. Gallia Levy saw the early clinical data around a potential hemophilia A drug that Roche affiliate Chugai Pharmaceutical had developed. Now it was coming to Genentech, and Levy wanted to be there, too.